C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof

Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
11/2002
11/06/2002	EP1254147A2 Nucleic acids, proteins, and antibodies
10/2002
10/31/2002	WO2002086503A1 Bacteriotoxin adsorbents and method of screening the same
10/31/2002	WO2002085926A2 Method for producing stable, regeneratable antibody arrays
10/31/2002	WO2002085519A2 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
10/31/2002	US20020160948 Such as preventing or treating primary cancer cell growth
10/31/2002	DE10118774A1 Verfahren zur Bestimmung der Substratspezifität einer enzymatischen Aktivität und Vorrichtung hierzu Method for determining the substrate specificity of an enzymatic activity and device for this purpose
10/31/2002	CA2444055A1 Bacteriotoxin adsorbents and method of screening the same
10/31/2002	CA2443562A1 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
10/30/2002	EP1252303A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252302A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252297A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252290A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252289A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252185A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252176A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP0907887A4 Engineering affinity ligands for macromolecules
10/30/2002	CN1377283A Process to make a sustained release formulation
10/24/2002	WO2002083933A2 Method for determining the substrate specificity of an enzymatic activity and a device therefor
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083872A2 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites
10/24/2002	US20020155588 Very large scale immobilized polymer synthesis
10/24/2002	US20020155547 Polypeptide for use in the treatment of cancer, hepatitis, multiple sclerosis, fibrosis, inflammatory or autoimmune diseases, cancers and viral diseases
10/24/2002	US20020155492 Arrays for detecting nucleic acids
10/24/2002	US20020155491 Arrays for detecting nucleic acids
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/23/2002	EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/22/2002	US6469136 Methods and composition for peptide synthesis
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/17/2002	WO2002081753A1 Method for identifying and characterizing individual dna molecules
10/17/2002	WO2002081683A2 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	WO2002081637A2 Peptides incorporating chemoselective functionalities
10/17/2002	US20020151708 DNA encoding proteins that inhibit Hsp70 function
10/17/2002	US20020151500 Administering a therapeutically effective amount of a type-5 selective somatostatin agonist to patient
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	CA2443067A1 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	CA2442645A1 Peptides incorporating chemoselective functionalities
10/16/2002	EP1098660B1 Encapsulation of water soluble peptides
10/16/2002	EP0973794B1 Netrin receptors
10/15/2002	US6465421 Promoting the growth of body and/or head hair and/or combatting the loss of such hair via cyclooxygenase treatment, as well as, contrariwise, retarding and/or preventing the growth of body/cranial hair via lipoxygenase treatment
10/10/2002	WO2002079415A2 Reducing the immunogenicity of fusion proteins
10/10/2002	WO2002079397A2 Virus derived antimicrobial peptides
10/10/2002	WO2002079232A2 Reducing the immunogenicity of fusion proteins
10/10/2002	WO2002012893A3 Microarrays of functional biomolecules, and uses therefor
10/10/2002	US20020146762 Generating mutant polypeptides; obtain protein sample, incubate wih mutagen, recover and evaluate protein activity
10/10/2002	US20020146414 Controlled release of non heparin-binding growth factors from heparin-containing matrices
10/10/2002	CA2442363A1 Reducing the immunogenicity of fusion proteins
10/09/2002	EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/08/2002	US6462172 Purification of tissue plasminogen activator (TPA)
10/03/2002	WO2002076489A1 Serum albumin binding moieties
10/03/2002	WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses
10/03/2002	US20020142394 Exonuclease-mediated gene assembly in directed evolution
10/03/2002	CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses
10/03/2002	CA2440582A1 Serum albumin binding moieties
10/01/2002	US6458931 Immunoassay, immunotherapy; cancer; side effect reduction
10/01/2002	US6458366 Compounds and methods for diagnosis of tuberculosis
10/01/2002	US6458349 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing
09/2002
09/26/2002	WO2002074950A1 Method of analyzing intermolecular interaction
09/26/2002	WO2002074797A2 Protein having multiple antigen/epitope sequences and being immobilized for the diagnosis of hiv infections
09/26/2002	WO2002062957A3 Ter sites and ter binding proteins
09/26/2002	US20020137096 Solid phase synthesis; photolithography
09/25/2002	EP1242460A2 Immobilisation of proteins using a polypeptide segment
09/24/2002	US6455503 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/19/2002	WO2002072865A2 Methods, kits and compositions of combination oligomers
09/19/2002	WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy
09/19/2002	WO2001036630A9 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
09/19/2002	CA2440773A1 Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules
09/19/2002	CA2439750A1 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
09/18/2002	EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
09/18/2002	EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof
09/17/2002	US6451971 Polypeptide cell adhesion inhibitors; antimetastasis and anticarcinogenic agents
09/17/2002	US6451543 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
09/17/2002	US6451536 Products for detecting nucleic acids
09/17/2002	US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection
09/17/2002	US6451311 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free n-procalcitonin; used as an in vitro or in vivo diagnostic agent
09/17/2002	CA2278878C Very large scale immobilized peptide synthesis
09/17/2002	CA2072420C Storage of materials
09/12/2002	US20020127244 Fractionating a mixture of polyethylene glycol(PEG)-protein adducts comprising partitioning the PEG/protein adducts in a PEG-containing aqueous biphasic system
09/11/2002	EP1238075A2 Chordin-like molecules and uses thereof
09/11/2002	EP1237940A1 Affinity macroligands
09/10/2002	US6447777 Polymerized staphylococcal protein a for treatment of diseases
09/10/2002	CA2258661C Synthetic phosphopeptides for treating bone diseases
09/06/2002	WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei
09/06/2002	WO2001013937A9 Peptides capable of modulating the function of cd66 (ceacam) family members
09/04/2002	EP1235914A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
09/04/2002	EP0904095B1 Chimeric isoprenoid synthases and uses thereof
09/04/2002	EP0789590B1 Chitosan induced immunopotentiation
09/04/2002	EP0771209B1 Novel peptides
09/04/2002	CN1367181A Method for synthesizing protein A immunoadsorption material for cleaning blood
08/2002
08/29/2002	WO2002066984A2 Arrays for determining binding of biomolecules
08/29/2002	WO2002066511A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
08/29/2002	WO2002066056A2 Synthetic vaccines comprising polyhydroxypolymer carriers
08/29/2002	US20020119510 Enzymatic polypeptide for use in screening bactericides
08/29/2002	US20020119473 Nucleotide sequence ligand for use in the detection diagnosis and treatment of cancer
08/29/2002	US20020119457 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide
08/29/2002	CA2440197A1 Synthetic vaccines comprising polyhydroxypolymer carriers
08/29/2002	CA2438415A1 Pixel arrays
08/29/2002	CA2436399A1 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders

1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 107